Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: A case report and review of the literature

• Published in: Pediatric Blood & Cancer Vol. 45; no. 3; pp. 333 - 339
• Main Authors: Shimonodan, Hidemi, Nagayama, Jun, Nagatoshi, Yoshihisa, Hatanaka, Michiki, Takada, Akiko, Iguchi, Haruo, Oda, Yoshinao, Okamura, Jun
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.09.2005; Wiley
• Subjects: acute lymphocytic leukemia; Adolescent; Biological and medical sciences; childhood and adolescence; Fatal Outcome; Female; General aspects; Humans; hypercalcemia; Hypercalcemia - blood; Hypercalcemia - etiology; Medical sciences; multiple osteolysis; Osteolysis - blood; Osteolysis - etiology; parathyroid hormone-related peptide; Parathyroid Hormone-Related Protein - blood; Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood; Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications; Recurrence; Tumors; Human; Pediatrics; Hydroelectrolytic balance disorder; Calcium; Acute; Malignant hemopathy; Lymphoblast; Osteolysis; Inorganic element; Case study; Hypercalcemia; Metabolic disorder; Cancerology; parathyroid hormone-related peptide; Lymphoproliferative syndrome; Parathyroid hormone related peptide; multiple osteolysis; Acute lymphocytic leukemia; Lesion; childhood and adolescence; Child; Bibliographic review
• ISSN: 1545-5009; 1545-5017; 1096-911X
• DOI: 10.1002/pbc.20357

Background Osteopathy is one of the common initial symptoms of acute lymphocytic leukemia (ALL) in children and adolescents, but multiple osteolysis accompanied by hypercalcemia is rarely observed. Procedure We treated a 14‐year‐old female who had multiple osteolytic lesions and hypercalcemia at initial onset of ALL. In this case we examined some humoral factors, which are known to associate with hypercalcemia in malignancies. Results Parathyroid hormone‐related peptide (PTHrP) was elevated in serum, and reverse transcriptase‐polymerase chain reaction and immunohistochemistry revealed that the lymphoblasts produced PTHrP directly. Other humoral factors related to hypercalcemia were not detected. ALL relapsed in the bone marrow 3 months after achieving complete remission, and hypercalcemia and elevation of serum PTHrP were also observed. A second remission could not be achieved and hypercalcemia continued. The patient received allogeneic bone marrow transplantation. The serum calcium level became normal after the conditioning therapy. Before engraftment, however, the patient died of infection. Conclusions The present case suggests that blast‐producing PTHrP might be associated with multiple osteolytic lesions and hypercalcemia. PTHrP expressed in the lymphoblasts may, in itself, confer a survival advantage to lymphoblasts and contribute to the refractory nature of the disease. © 2005 Wiley‐Liss, Inc.